Sacubitril‐valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO‐SAS study

AIMS: Optimizing medical cardiac treatment for sleep apnoea (SA) in patients with chronic heart failure and reduced ejection fraction (HFrEF) is an expert Grade C recommendation based on six studies encompassing a total of 67 patients only. Whether sacubitril–valsartan (SV), a cornerstone of HFrEF m...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaffuel, Dany, Nogue, Erika, Berdague, Philippe, Galinier, Michel, Fournier, Pauline, Dupuis, Marion, Georger, Frédéric, Cadars, Marie‐Pierre, Ricci, Jean‐Etienne, Plouvier, Nathalie, Picard, François, Puel, Vincent, Mallet, Jean‐Pierre, Suehs, Carey M., Molinari, Nicolas, Bourdin, Arnaud, Roubille, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318447/
https://www.ncbi.nlm.nih.gov/pubmed/34102018
http://dx.doi.org/10.1002/ehf2.13455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318447/
https://www.ncbi.nlm.nih.gov/pubmed/34102018
http://dx.doi.org/10.1002/ehf2.13455

Ejemplares similares